Author

Sarah Batten

Auburn UniversityORCID 0009-0007-9854-9091Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Amit MitraiD· 1 shared Farnaz HemmatiiD· 1 shared Farshad AmiriiD· 1 shared Panagiotis MistriotisiD· 1 shared Robert Arnold· 1 shared Sayak Chakravarti· 1 shared Suman MazumderiD· 1 shared Taraswi Mitra GhoshiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amit MitraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 30, 2026

Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer

Sayak Chakravarti, Suman Mazumder, Farnaz Hemmati…·Amit Mitra

This paper demonstrates that TAK-715, a dual inhibitor of p38α MAPK and casein kinase δ/ϵ, effectively treats taxane-resistant and aggressive prostate cancer by targeting cancer stemness and mitochondrial dysfunction.

DOI 10.64898/2026.09.29.754128

humanbulk RNA-seq

𝕏 PostBluesky